Core Viewpoint - The company expects a significant increase in net profit for the fiscal year 2025, projecting a net profit attributable to shareholders of between 85 million to 105 million yuan, representing a year-on-year increase of 44.48 million to 64.48 million yuan, or a growth of 109.78% to 159.14% [1] Group 1 - The substantial profit growth is primarily attributed to the company's stable and positive performance in its main business [1] - Continuous optimization of marketing strategies and strengthening of channel construction have led to a steady increase in the sales volume of major products, driving revenue growth [1] - The company is advancing management reforms and implementing cost reduction and efficiency enhancement measures, resulting in a decrease in unit costs that outpaces price adjustments, thereby improving gross margins and overall profitability [1]

Core Viewpoint - Jindan Technology (300829.SZ) expects a significant increase in net profit for 2025, projecting a range of 96 million to 138 million yuan, representing a year-on-year growth of 156.06% to 268.09% [1] - The company anticipates a net profit of 70 million to 100 million yuan after deducting non-recurring gains and losses, indicating a substantial increase of 335.17% to 521.67% compared to the previous year [1] Group 1 - The company will launch a 50,000-ton lactic acid expansion and renovation project in 2025, which is expected to enhance the production and sales of its main products [1] - The increase in operational performance is attributed to a decrease in procurement costs for corn and shipping fees, among other operating cost reductions [1]

1月29日，A股三大指数涨跌不一。截至收盘，沪指涨0.16%，报4157.98点，深成指跌0.3%，报14300.08点，创业板指跌 0.57%，报3304.51点。从板块行情上来看，今日表现最好的是白酒板块，出现涨停潮，其次表现较好有超级品牌和AI智能 体，而中芯概念、存储芯片和PCB等板块下跌。 | 基金经理 | 基金名称 | 基金代码 | 公告日期 | 变动日期 | 任职状态 | 变动原因说明 | | --- | --- | --- | --- | --- | --- | --- | | 张立晨 | 华泰保兴安盛 | 007385 | 2026/1/29 | 2026/1/29 | 在职 | 开始任职 | | 快訊團 | 广发恒生生物科技ETF | 691691 | 2026/1/29 | HULL | 在职 | 开始任职 | | 吴秋松 | 东方阿尔法优势产业混合A | 009644 | 2026/1/29 | 2026/1/28 | 在职 | 开始任职 | | | 东方阿尔法优势产业混合C | 009645 | 2026/1/29 | 2026/1/28 | 在职 | 开始任职 | | 王栋 | 路 ...

（记者 曾健辉） 每经头条（nbdtoutiao）——水贝黄金平台"杰我睿"兑付危机调查：40倍杠杆对赌，金价越涨平台越 亏！老板自称"还在深圳"，投资者：兑付方案本金打两折，无法接受 每经AI快讯，金丹科技1月29日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润9600万元 ~1.38亿元，同比增长156.06%~268.09%；业绩变动主要原因是，2025年度公司计提相应资产减值准备较 2024年度减少，对当期业绩的影响较同期有所降低。2025年度公司年产5万吨乳酸扩产改造项目投产， 公司主营产品产量及销量进一步得到提升，叠加玉米采购成本、海运费等营业成本下降因素，推动公司 经营业绩较同期实现增长。受前述因素影响，公司整体利润呈现大幅增长态势。 ...

Core Viewpoint - The company expects a significant increase in net profit for the year 2025, driven by strong performance in its main business and effective cost management strategies [1] Financial Performance - The company anticipates a net profit attributable to shareholders of 85 million to 105 million yuan for 2025, representing a year-on-year increase of 109.78% to 159.14% [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between 80 million to 100 million yuan, reflecting a year-on-year growth of 99.15% to 148.94% [1] Business Strategy - The growth in profit is attributed to the steady improvement in the company's main business, supported by optimized marketing strategies and strengthened channel development, leading to a steady increase in product sales [1] - The company is actively pursuing management reforms and implementing cost reduction and efficiency enhancement measures, which include refined management practices and improved operational efficiency [1] Profitability Enhancement - The reduction in unit costs of main products has outpaced the adjustments in selling prices, resulting in a continuous improvement in gross profit margins and overall profitability [1]

金丹科技公告，预计2025年度净利润为9600万元-1.38亿元，同比增长156.06%-268.09%。2025年度公司 计提相应资产减值准备较2024年度减少，对当期业绩的影响较同期有所降低。2025年度公司年产5万吨 乳酸扩产改造项目投产，公司主营产品产量及销量进一步得到提升，叠加玉米采购成本、海运费等营业 成本下降因素，推动公司经营业绩较同期实现增长。 ...

Core Viewpoint - The company expects significant growth in net profit for the year 2025, with projections indicating an increase of 109.78% to 159.14% year-on-year, driven by improved operational efficiency and sales growth in its main business [1] Financial Performance - The estimated net profit attributable to shareholders for 2025 is projected to be between 85 million and 105 million yuan [1] - The estimated net profit after deducting non-recurring gains and losses is expected to be between 80 million and 100 million yuan, reflecting a year-on-year increase of 99.15% to 148.94% [1] Business Strategy - The company's main business is showing a stable and positive trend, supported by continuous optimization of marketing strategies and strengthened channel development [1] - The company has implemented management reforms and cost-reduction measures, enhancing operational efficiency and leading to a greater reduction in unit costs compared to price adjustments [1] Profitability Enhancement - The improvements in management and operational efficiency have resulted in a sustained increase in gross profit margins, thereby enhancing overall profitability [1]

南财智讯1月29日电，吉华集团发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 5170.00万元，同比预减69.64%；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为 280.00万元，同比预减90.76%。本期业绩预减的主要原因：公司本期归属于母公司所有者的非经常性损 益净额约为4890.00万元，较去年同期下降65.08%，主要系上期公司全资孙公司响应政府要求，对部分 资产进行拆迁确认资产处置收益15939.43万元。 ...

2026年1月29日，红 宝 丽（sz002165）触及涨停，涨停价11.77元，涨幅10%，总市值86.54亿元，流通 市值85.64亿元，截止发稿，总成交额28.65亿元。 根据喜娜AI异动分析，红 宝 丽涨停原因可能如下，环氧丙烷项目+业绩增长+资金储备： 1、公司主要 从事环氧丙烷等产品的研发、生产和销售，其环氧丙烷项目进入试生产阶段，已完成审批和主要建设， 即将投产，这将增强公司产能和产业链协同。此项目有望为公司带来新的盈利增长点，推动公司业绩进 一步提升。 2、红宝丽第三季度净利润大幅增长57.96%，扣非净利润增长255.37%，显示季度业绩显著 改善。另外，公司货币资金较年初增加89.68%，资金储备充足，占总资产比19.33%，这为公司的业务 发展提供了有力的资金支持。 3、从市场表现来看，近期该股多次登上龙虎榜，资金博弈较为激烈。 2026年1月27日龙虎榜显示游资和机构净买，外资净卖；1月28日机构净卖，外资净买。在化学制品板块 中，资金的活跃流动可能促使板块内股票产生联动效应。可能是部分资金看重公司环氧丙烷项目前景和 业绩改善情况，从而推动股价涨停。 声明：市场有风险，投资需谨慎。本文 ...

Group 1: Lier Chemical - Lier Chemical is a global leader in chlorinated pyridine herbicides and a leading company in glyphosate and refined glyphosate, with products sold in over 30 countries and regions [1] - The core growth logic is driven by the accelerated ban on glyphosate, with the market size for glyphosate expected to grow from 3 billion yuan in 2020 to 8 billion yuan in 2025, representing a compound annual growth rate (CAGR) of 22% [1] - Lier Chemical is the second company globally and the first in China to master the industrialization of cyanopyridine chlorination technology, with a total production capacity exceeding 50,000 tons per year, achieving full production and sales [1] - The company has a market share of over 70% globally, with more than 80% of its sales coming from long-term supply agreements, and both product categories are currently in a price increase cycle [1] - The company has seen its performance improve by over 100% for three consecutive quarters [1] Group 2: Shandong Heda - Shandong Heda is the absolute leader in cellulose ether in China and a core supplier of plant capsules globally, with raw materials sourced from cotton, wood, and bamboo [2] - The focus is on medical-grade and food-grade cellulose ether, with profit margins reaching 25% to over 35%, particularly for medical-grade cellulose ether, which sees annual price increases and growing margins [2] - The company has established long-term supply agreements with major domestic pharmaceutical companies such as Heng Rui and Shi Yao, as well as international firms like Pfizer, Novartis, and Bayer, supplying 15 out of the top 20 global pharmaceutical companies [2] - The global capsule market is over 30 billion yuan, with the share of plant capsules expected to increase from 15% in 2020 to 30% in 2025, reflecting a CAGR of over 20% as a clear trend to replace gelatin capsules [2] - Shandong Heda has a domestic production capacity of 20 billion capsules per year, with a $500 million investment in the U.S. to build a project with the same capacity, expected to be operational by Q3 2026 [2]